NEWS Rogaratinib plus atezolizumab shows encouraging safety, efficacy in urothelial carcinoma Urology Times Randy Sweis, MD, Is on the Leading-Edge of Cancer Care Conquer Cancer: The ASCO Foundation Top Questions about Metastatic Kidney Cancer, Answered HealthCentral Rogaratinib/Atezolizumab in Cisplatin-Ineligible FGFR mRNA-Overexpressing Urothelial Cancer The ASCO Post FORT-2 trial shows promising results for bladder cancer immunotherapy combination News-Medical HemOnc Today honors Next Gen Innovators Healio Immune System Agents May Move into Earlier Settings in GU Cancers OncLive Bladder Cancer: Treatment Updates CancerCare
